Androgen, estrogen and progestin binding in cytosols of benign gynecologic tumors and tumor-like lesions

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-07, 2026-07-09

This study investigated androgen, estrogen, and progestin binding in benign gynecologic tumors, finding simultaneous androgen and progestin receptors were common, and all three receptors were present in one endometrioma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text

The paper investigated binding characteristics of androgens, estrogens, and progestins in cytosols from benign gynecologic tumors and tumor-like lesions, reporting specific dissociation constants for androgen (Kd 0.27±0.06 nM), estrogen (Kd 0.19±0.04 nM), and progestin (Kd 0.22±0.07 nM). A common finding was that androgen and progestin receptors were simultaneously present. It also reported that in one endometrioma, specific binding for androgen, estrogen, and progestin was observed simultaneously. This paper is centrally about endometriosis — it includes an endometrioma demonstrating concurrent androgen, estrogen, and progestin binding in cytosol.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Specific androgen (Kd 0.27 +/- 0.06 nM), estrogen (Kd 0.19 +/- 0.04 nM) and progestin (Kd 0.22 +/- 0.07 nM) binding were investigated in benign gynecologic tumors and tumor-like lesions. The simultaneous presence of androgen and progestin receptors was a common finding. In one endometrioma, specific androgen, estrogen and progestin binding was observed simultaneously.
Full text 927 characters · extracted from oa-doi-fallback · click to expand
Subscribe to RSS Please copy the URL and add it into your RSS Feed Reader. https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000025.xml Horm Metab Res 1985; 17(11): 607-609 DOI: 10.1055/s-2007-1013618 DOI: 10.1055/s-2007-1013618 Clinical © Georg Thieme Verlag, Stuttgart · New York Androgen, Estrogen and Progestin Binding in Cytosols of Benign Gynecologic Tumors and Tumor-Like Lesions Further Information Publication History 1983 1984 Publication Date: 14 March 2008 (online) Summary Specific androgen (Kd 0.27±0.06 nM), estrogen (Kd 0.19±0.04 nM) and progestin (Kd 0.22±0.07 nM) binding were investigated in benign gynecologic tumors and tumor-like lesions. The simultaneous presence of androgen and progestin receptors was a common finding. In one endo-metrioma, specific androgen, estrogen and progestin binding was observed simultaneously. Key-Words: Androgen - Estrogen and Progestin Receptors - Gynecologic Tumors

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometrioma

MeSH descriptors

Ovarian Neoplasms Receptors, Androgen Receptors, Estrogen Receptors, Progesterone Adult Aged Cystadenoma Cystadenoma Cytosol Cytosol Dysgerminoma Dysgerminoma Endometriosis Endometriosis Female Humans Middle Aged Ovarian Cysts Ovarian Cysts Ovarian Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-06T06:07:45.168820+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine